Obesity and pharmacology experts are warning about hidden safety risks and efficacy issues for many types of medications in people with obesity.
In a decision signed Monday, North Carolina federal judge Kenneth Bell granted Merck’s motion to dismiss the claims of ...
In the second trial, which was open label, 95.6% of participants who switched to DOR/ISL maintained viral suppression ...
The list price of Mavenclad is around £2,050 per 10mg tablet, although, Merck is providing it to the NHS in England at a ...
The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...
Stephen Krahling was a published cancer researcher when vaccine maker Merck brought him on board as a virologist in 1999. That’s when he says he found himself embroiled in an all-hands-on-deck ...
The combination demonstrated non-inferiority to comparator antiretroviral therapies, meeting the primary efficacy success ...
Hint: It's all in the suffix. Viagra, Prozac, Xanax, and Zoloft all went through a process to select memorable names.
Merck (MRK) announced the presentation of “positive” results from two pivotal Phase 3 trials of the investigational, once-daily, oral, two-drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback